SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " dru " 1,973 found 🔀 AI-powered Shuffle
DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair - DCAT Value Chain Insights
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the…
‘Has He Been Drugged?’
In a new memoir, Jill Biden recounts her husband’s calamitous debate night.
France to reimburse weight-loss drugs from mid-June, health minister says
France will reimburse the cost of weight-loss drugs for severely obese patients from mid-June, Health Minister Stephanie Rist said on Thursday in an interview with TF1 channel.
New depression treatment targets the immune system instead of the brain
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
Enhanced Games offers $10 million prize to sprinter who breaks Bolt's 100m record
Enhanced Games organizers said on Wednesday they will offer a $10 million bonus to any man who breaks Usain Bolt's 100 metres world record at their 2027 event, sharply increasing the financial stakes for the controversial, drug-friendly competition.
Expected NC budget won’t restore GLP-1 weight-loss drug coverage for state employees, treasurer says
State Treasurer Brad Briner doesn’t expect North Carolina lawmakers to include funding in the upcoming budget to restore State Health Plan coverage of GLP-1 drugs for weight loss, as costs and competing budget priorities keep the benefit off the table.
Prasugrel after PCI outperforms other common antiplatelet drugs
"Prasugrel provided the optimal balance between efficacy and safety," researchers noted in a new meta-analysis.
Powering drug discovery with analytical chemistry
Advances in analytical instrumentation are helping researchers study drug behavior, improve biomedical research, and train the next generation of scientists.
Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
Business owner considers leaving Hamilton Avenue after shooting damages store
Quality Appliances hit by gunfire as quadruple shooting injures four in Northside
Russia summons Czech envoy over Orthodox cleric's drug arrest
The once-powerful bishop denies links to narcotics trafficking
Watch Lilly Gets Back Into the Vaccine Business With New Deals
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion as it looks to become a leader in infectious diseases. The drugmaker has been using cash from its obesity drugs to expand into other disease areas. Bloomberg's Gerry Smith reports.
Drug-testing bill gains momentum
A bill to prohibit medically unnecessary and nonconsensual drug testing of pregnant and postpartum women and newborns is gaining momentum in the state Legislature.
At the Enhanced Games, drugs don’t get athletes banned. They could get them rich.
The inaugural Games took place Sunday in Las Vegas, where aging Olympians competed for large payouts, most of them after having taken cocktails of performance-enhancing drugs.
A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down
USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity.
5 more things to know about 3 hospitals’ $250M case against CVS
Last week hospitals owned by three big health systems filed suit against CVS Health. The trio filed separately, but all accuse the corporation of robbing them of funds they’re owed through the federal 340B drug pricing program.
🚨 BREAKING | Allegri at Milan, sacking close! 😱
The earthquake at Milan now seems close to shaking the Rossoneri bench as well. After last night’s heavy debacle against Cagliari, according to Matteo Moretto, Massimiliano Allegri’s future is ha...
One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.
One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.
Common heart drug taken by millions found useless
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for patients whose heart function remained normal, despite being given to millions worldwide. Even more surprising, women taking the drugs faced a higher risk of death, repeat heart attack, or hospitalization for heart failure compared to women who didn’t receive them.
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
Cancer nearly left my kids without a mom. Funding cuts may halt the science that saved me.
Jenney Bitner: I'm not a scientist or policy expert. But I know that the drug that kept me alive for my children was built on a foundation of public investment.
Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say
Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially reducing relapse and neural damage.
How the Silicon Valley-backed steroid Olympics aim to get everyone hooked
As biohacking gains momentum among elites including Robert F. Kennedy Jr., the Peter Thiel-backed Enhanced Games aims to normalize longevity drugs through a Vegas sports spectacle. Critics call the premise dangerous and unethical.
Pancreatic cancer seemed ‘undruggable,’ then scientists cracked a key target
An experimental pill has shown unprecedented success, upending conventional wisdom about the disease.
Pancreatic cancer seemed ‘undruggable,’ then scientists cracked a key target
An experimental pill has shown unprecedented success, upending conventional wisdom about the disease.
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
Wegovy linked to rare “eye stroke” that can cause sudden blindness
A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudden vision loss. The study, based on millions of FDA side-effect reports, found the risk signal was nearly five times stronger for Wegovy than for Ozempic, despite both containing semaglutide.
Science news this week: Laotian 'death jar', climate change threatens rice crops, and an asthma drug treats tough cancer
May 23, 2026: Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the weekend
Bond breakout? Big effects of bad data. Immigration and thermostatic politics & dad-chat is coming for dad-books.
Thank you for opening your Chartbook email. Anna Airy, A Shell Forge at a National Projectile Factory, Hackney Marshes, London, 1918 Bond breakout - John Authers Across the developed markets, bond markets are staging a slow-motion car wreck. Looking at the drastic moves in the US, Japan, the UK and France, Barclays’ Ajay Rajadhyaksha commented: “Last week, long bonds broke. Not in one country. In all of them. Simultaneously. Four countries. Four different political systems. Four different central banks. But the same trade — “get me out of duration!”” Each country has its own contributing political problems, but the uniformity of the shift out of long-term bonds with high duration makes clear that something broader is afoot. For Rajadhyaksha, it is “simple and uncomfortable.” The developed world “has too much debt, too little fiscal discipline, and no political appetite for fixing either.” If there’s a trigger, it has been the Iran war and the resulting shock to oil supply. Source: Bloomberg G7 countries are now borrowing at rates that were enjoyed by EM in the early 2020s For contributing subscribers only. Subscribe Trade between China and Russia has grown in recent years For contributing subscribers only. Subscribe Big effects of bad data A decade ago nearly nine in ten Americans, when approached, agreed to fill out the Current Population Survey, which is administered to about 60,000 households each month and asks about, among other things, employment. Fewer than seven in ten do so now (see chart 1). For the Consumer Expenditure Survey, which tries to capture 3,700 households monthly, the response rate is down from 68% to 40%. … When the information becomes less reliable, investment decisions get more difficult to make. Some may be delayed, creating a potential drag on the economy. A new working paper by Nicholas Bloom of Stanford University, Erica Groshen, former head of the Bureau of Labour Statistics (BLS) now at Cornell University, and Duncan Hobbs and Michael Strain of the American Enterprise Institute, a think-tank, hazards an estimate. Preserving trust in “the integrity and quality of official statistics”, the authors claim, generates economic benefits of about $25 for every $1 spent on the BLS, the agency with an annual budget of $700m that is responsible for many of these data. To arrive at their conclusion the quartet analysed an ignoble episode in the BLS’s recent history. On August 1st 2025 Donald Trump sacked Erika McEntarfer, appointed as the agency’s commissioner by his predecessor, Joe Biden. The president alleged, without evidence, that the BLS’s steep downward revision to recent jobs numbers had been “RIGGED in order to make the Republicans, and ME, look bad”. In fact, it was the wanton dismissal that looked bad in the eyes of many observers. In the following seven days there was a 50% leap, relative to the week before, in the average value of the index of Economic Policy Uncertainty (EPU), which tracks the number of articles mentioning such uncertainty that are published daily in American newspapers. This was a discernible jump even when compared to the chaos caused by Mr Trump’s trade war in April 2025 and his real one in Iran in the past two months (see chart 2). Based on Mr Bloom’s earlier study with other colleagues of the EPU’s impact on business investment, industrial production and employment, the authors estimate that the jump reduced American GDP by over $100bn (0.3%) and non-farm payrolls by 168,000 (0.1%). Source: The Economist Immigration and thermostatic politics (Sarah O’Connor in the FT) A strange thing happened a year and a half ago. No sooner had Americans elected Donald Trump as president on an explicitly anti-immigration platform than US public opinion began to swing much more favourably towards immigration. … to political scientists who study “thermostatic” politics, this development is no surprise at all. Public opinion often moves against the prevailing party, especially if they are perceived to have gone “too far” in one direction. The phenomenon was first explored in the 1990s with reference to fiscal policy, but in recent years it has been particularly evident in the realm of immigration policy. While these swings in opinion polls can make it seem as if people don’t know their own minds, they can be a useful democratic check on governments by sending bright flashing warning lights when policies stray too far from the public’s comfort zone. The problem comes when politicians misinterpret those signals. When people tell pollsters they want less immigration, or think it is bad for the country overall (or the converse), they are often expressing an opinion about how things appear to be going in that moment relative to their preferences, rather than a deep shift in their underlying views. According to Alexander Kustov, a political scientist, most Americans’ views are quite stable and moderate: they support immigration that is controlled and in the national interest, and oppose flows that are disorderly or under-enforced. In the US, he argues the Trump administration over-interpreted dissatisfaction with high immigration under Joe Biden, and implemented policies that went too far for many voters. “People don’t necessarily change their idea about their ideal immigration policy, but they can react to what the government is currently doing,” he told me. “A lot of people are not happy with what the Trump administration are doing — right now we’re not talking about border enforcement, we’re talking about people not just getting harassed, but killed.” But similarly, he added, pro-immigration advocates would be making a mistake to interpret the recent, more favourable swing towards immigration as a deep-seated ideological shift in attitudes. The recent history of UK immigration policy offers another cautionary tale. After the 2016 Brexit referendum, public concern about immigration fell. This was partly because net migration statistics declined, but also because people felt a sense of catharsis and control, says Sunder Katwala, director of British Future, a think-tank. By 2019, the public ranked immigration as only the ninth biggest issue of concern, according to Ipsos polling. But when the Conservative government liberalised visa routes for students and care workers between 2019 and 2022, that helped net migration to surge. And so, too, did public concern. Today’s Labour government has implemented another sharply restrictive turn in immigration policy. As Kustov and researcher Caitlyn Yates argue, thermostatic public opinion should be a useful check on politicians. Instead it seems to have helped to magnify the pendulum swing in the UK. The government over-interprets and overreacts to a change in public opinion, which reacts in turn, prompting a sudden swing the other way. Source: Financial Times HEY READERS, THANK YOU for opening the Chartbook email. I hope it brightens your day. I enjoy putting out the newsletter, but tbh, what keeps this flow going is the generosity of those readers who clicked the subscription button. If you are persuaded to click, please consider the annual subscription of $50. It is both better value for you and a much better deal for me, as it involves only one credit card charge. Why feed the payments companies if we don’t have to. Subscribe Anna Airy, Shop for Machining 15-Inch Shells: Singer Manufacturing Company, Clydebank, Glasgow, 1918 Racing for a vaccine … we have been here before! The deadly Ebola outbreak in two African countries driven by a virus species with no vaccine has triggered an urgent search for a potential jab, in a test of troubled global efforts to avert threats posed by emerging diseases. A World Health Organization advisory group is due to would meet on Tuesday to recommend candidate jabs to prioritise for clinical trials, the global health body said. It will assess data including an analysis by the Coalition for Epidemic Preparedness Innovations (Cepi), which was set up after failures in the international response to a previous Ebola crisis. The latest Ebola outbreak in Democratic Republic of Congo and Uganda has infected hundreds of people and killed more than 80, health authorities say. Cepi’s reaction will be a crucial indicator of its progress towards its wider goal of producing vaccines for pandemic threats in just 100 days, despite steep cuts to international health funding. “If there was ever a time that we could show the world why Cepi is needed and show the world why the 100-day mission is needed, it’s now,” Nicole Lurie, the organisation’s executive director for preparedness and response, told the FT. “We’re happy to accept that responsibility, but obviously we need help from partners — particularly financial help in the long run.” DR Congo and Uganda would make the final decision on whether to press ahead with any vaccine candidates endorsed for clinical trials by the WHO experts, the global health body said. “Other ethical and community acceptability issues will be considered,” said the WHO, which declared the latest outbreak a public health emergency of international concern on Sunday. “This will be important to make sure that the trial, if it happens, will be adequately communicated to the population.” Lurie said Cepi had provided information from a survey of research teams and companies working on drugs that might be effective against the Bundibugyo virus behind the outbreak. The organisation hoped soon to announce partners in the quest for a jab, she added, although she declined to give a timescale for when one might be developed. Cepi’s Nicole Laurie said global health bodies were ‘getting some live-fire drills’ with hantavirus and the latest Ebola outbreak. The hunt for a vaccine should be helped by scientific advances including the use of artificial intelligence to find drugs active against viruses, Lurie said. Existing jabs against the Zaire Ebola virus responsible for many previous outbreaks might provide a basis for tackling the Bundibugyo species, she added. “We’ll see how far and how fast we can get,” Lurie said, adding that Cepi had done preliminary work recently on a possible jab for the rat-borne hantavirus responsible for a recent fatal outbreak on a cruise ship. “Both with hantavirus and now with Ebola, [we] are getting some live-fire drills.” Source: Michael Peel in the Financial Times Dad-chat is coming for dad-books. (By Pamela Paul and Jeffrey A. Trachtenberg in the WSJ) They were the go-to gifts for Father’s Day: a book about some little-known chapter of World War II, the sweeping narrative of a shipwreck, perhaps the latest presidential biography. These days, dad books are a dying breed. Nonfiction book sales have been in decline for the past four years, and are now the most challenged segment of the print book market. Publishers say certain types of books still fare well—including celebrity memoirs and religious titles. But in recent years, print sales in such categories as biography, current affairs and business and economics—what publishers refer to as “serious nonfiction” and which tend to resonate especially with men—have fallen considerably. Sales of nonfiction print titles were down nearly 8% through May 9 this year, and sales of books about politics and current affairs were down 19%, according to book tracker Circana BookScan. Publishing has long been subject to cyclical changes, with trends in format and genre taking over bookshelves in grand sweeps. (Remember the adult coloring-book craze? Or the stratospheric rise of romantasy?) But many in publishing believe the decline in serious nonfiction is more existential. “The trend couldn’t be clearer,” said Jonathan Karp, the former chief executive of Simon & Schuster and publisher of the new Simon Six imprint. “This is a sea change and people should wake up and realize we’re living in a new world.” One culprit for the shift: a new media diet for fans of more serious nonfiction. … Sixty-two percent of men and 54% of women consumed a podcast in the prior month, according to a recent survey by Edison Research at SSRS, up from 46% and 39%, respectively, in 2023. “When we have internal meetings to talk about this problem, it always comes around to podcasts,” said Jonathan Burnham, president and publisher of the Harper Group at HarperCollins Publishers. “The man who wants to read American history is now tuning into one of the many good podcasts about history that lends the quiet attention to a serious subject he’s looking for. It makes the idea of sitting down with a 700-page Ron Chernow book less appealing. You’ve scratched that itch.” Source: Wall Street Journal Remarkable report by Novara from the nationalist rally in London in mid May. Anna Airy, Leopard Moth and Plums, 1915 If you’ve scrolled this far, you know you want to click: Subscribe
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.
The Enhanced Games is here. But forget the ‘sport’ – it has something it wants to sell you
A competition where drug taking is legal may appeal and intrigue in equal measure, but the bottom line is what counts
Inflammation may help explain how GLP-1 drugs prevent AFib
Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026.
GLP-1 Drugs Are Causing Frailty | Health for May 22
Plus, why one writer wants everyone to bail on Botox and how natural food colors are linked to health problems
A new sporting event’s controversial pitch: Performance-enhancing drugs welcome
The Enhanced Games, taking place this weekend in Las Vegas, support “safe, responsible, and clinically supervised use of performance enhancements.”
Burlington signs suggest 911 alternatives for mental health, drug call
The city is set to print 100 or so signs for about $3,000 that will include a wide range of contacts for handling mental health, drug and other calls.
5 Notable Moments From Candace Owens’s Warm Interview With Hunter Biden
In a nearly two-hour conversation, Mr. Biden discussed his addiction to drugs and alcohol, and Ms. Owens apologized for her past remarks about him.
Popular weight loss drugs like Wegovy may also target arthritis inflammation
Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Popular Weight Loss Drugs May Have Surprising Side Effect: Stalling Cancer
A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more research is needed to confirm the findings.
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug
Not only does it have a tongue-twisting name, “orforglipron” has a complex molecular structure that made its synthesis very challenging. A massive effort by chemists at the Eli Lilly pharmaceutical
New obesity drug helped patients lose up to 85 pounds in trial
A new experimental obesity drug from Eli Lilly helped patients lose an average of about 85 pounds in a late-stage clinical trial. Duke Health expert Dr. Susan Spratt says the results are reaching levels typically only seen with gastric bypass surgery.
Tucson Roadrunners Set Franchise Business Records During 2025-26 Season
While the Tucson Roadrunners celebrated their 10th anniversary on the ice during the 2025-26 season, the organization also delivered one of the most successful business campaigns in franchise history off it.
Waste Watch: How community colleges spent taxpayer-funded mental health recovery dollars
WLOS News 13 provides local news, weather forecasts, traffic updates, notices of events and items of interest in the community, sports and entertainment programming for Asheville, NC and nearby towns and communities in Western North Carolina and the Upstate of South Carolina, including the counties of Buncombe, Henderson, Rutherford, Haywood, Polk, Transylvania, McDowell, Mitchell, Madison, Yancey, Jackson, Swain, Macon, Graham, Spartanburg, Greenville, Anderson, Union, Pickens, Oconee, Laurens, Greenwood, Abbeville and also Biltmore Forest, Woodfin, Leicester, Black Mountain, Montreat, Arden, Weaverville, Hendersonville, Etowah, Flat Rock, Mills River, Waynesville, Maggie Valley, Canton, Clyde, Franklin, Cullowhee, Sylva, Cherokee, Marion, Old Fort, Forest City, Lake Lure, Bat Cave, Spindale, Spruce Pine, Bakersville, Burnsville, Tryon, Columbus, Marshall, Mars Hill, Brevard, Bryson City, Cashiers, Greer, Landrum, Clemson, Gaffney, and Easley.
Welcome to the Enhanced Games, where doping is encouraged
The Enhanced Games are here to destigmatize conventional wisdom about performance enhancing drugs.
Drug-enhanced sports: 'Clown show' or the future?
More than 40 athletes, most using performance-enhancing drugs, will compete in the Enhanced Games in a competition that seeks to upend sporting norms.
Highly Critical Drupal Core Flaw Exposes PostgreSQL Sites to RCE Attacks
Drupal released security updates for a highly critical Drupal Core vulnerability affecting sites that use PostgreSQL.
BSD YouTube Show: Penn State Football Trivia
We are in the doldrums of the college football offseason so we’re going to pass the time with some Penn State football trivia. 10 rounds, 10 topics, only one of Tim or Jared will leave victorious. We’ll be live on YouTube tonight at 7 p.m. EST. Come join! The audio will be on Spotify and […]
Common asthma drug helps fight hard-to-treat cancers, including aggressive breast cancers, early study finds
Scientists found that blocking a protein best known for its role in asthma enhances cancer immunotherapy in preclinical models.
Drupal critical update to fix bug with high exploitation risk
Drupal has announced a "core security release" scheduled for later today, warning that threat actors might develop exploits within hours of the update disclosure.
Musical reviews: 'Brigadoon' soars, 'Flower Drum Song' falters
'Brigadoon' soars at Pasadena Playhouse but 'Flower Drum Song' only intermittently comes to life at Little Tokyo's Aratani Theatre despite best intentions.
New drug approach offers hope for patients with recurrent aggressive cancers
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Dartmouth Health study could point way to sustained weight loss for those who stop using GLP-1 drugs
GLP-1 drugs have transformed obesity treatment, but many patients regain weight after stopping the medication. A new study could point the way to a solution.
Scientists use light to create tiny molecules that could transform medicine
Researchers have developed a light-driven method for creating tiny, high-energy “housane” molecules that are valuable for drug development and materials science. These compact ring-shaped structures are difficult to produce because of the intense internal strain they contain. By using photocatalysis and carefully tuning the starting molecules, the team managed to guide the reaction into a clean and efficient pathway.
Phil Collins makes rare public appearance months after revealing devastating health issues
Phil Collins made a rare public appearance in London over the weekend with his ex-wife, Jill Collins, along with Rod Stewart and Penny Lancaster. The former Genesis drummer will be inducted into the Rock & Roll Hall of Fame in November.
Two AI-based science assistants succeed with drug-retargeting tasks
Both tools generate hypotheses; one goes on to analyze some of the data.
FDA approves first-in-class hypertension drug from AstraZeneca
The pivotal trial for baxdrostat showed nearly double-digit placebo-adjusted systolic blood pressure reduction.
Cleaning can have meditative and other mental health benefits
It's spring cleaning season, and for some people that means drudgery or anxiety. But experts from Zen monks to psychologists say there can be mental health benefits found in such everyday manual chores as sweeping, mopping and clearing away clutter.
Pentagon watchdog evaluating US operations involving strikes on alleged drug boats
The Defense Department’s internal watchdog has said it is evaluating US Southern Command’s operations that have included strikes on alleged drug-trafficking boats in the Caribbean Sea and Pacific Ocean.
What Is ‘Ozempic Personality’? Patients Say GLP-1 Left Them Emotionally Flat
Some patients taking GLP-1 weight-loss drugs report less pleasure and excitement in life. “It is not in their heads,” doctor says. How to get help if you’re feeling less joy on the medication.
SimonMed hopes to drum up whole-body MRI business
The Tucson, Arizona-based radiology practice announced it will offer 20% discounts on its longevity scans to the military, veterans and first responders.
Kudos to Cheer Club, College of Business faculty, Cybersecurity team and more
Becky Cottrell, Ph.D., Department of Social Work, and Bridget Arend, Ph.D., School of Education Becky Cottrell from the Department of Social Work and Bridget Arend, Ph.D., from the School of Education co-authored an article recently published in an international journal. Read the article. Biff Baker, Ph.D., College of Business Biff Baker, Ph.D., received a Best in Track award from the Society for Advancement of Management for research examining bureaucratic inefficiencies within Section 8 subsidized housing programs. The study focuses on how administrative delays and communication breakdowns can create housing instability for families and discourage landlord participation. It also offers recommendations to improve accountability and trust in public housing systems. Brendan Fry, Ph.D., Department of Mathematics and Statistics Brendan Fry, Ph.D., professor in the Department of Mathematics and Statistics, co-authored the article “Modeling the Impact of Venous Collapsibility on Retinal Oxygenation,” published in the Journal of Theoretical Biology. The interdisciplinary research brought together scholars from the University of Delaware, Indiana University Indianapolis, McGill University and the Icahn School of Medicine at Mount Sinai Hospital. Access the article. Bridget Arend, Ph.D., School of Education Bridget Arend, Ph.D., professor in the School of Education, co-published the book “Facilitating Seven Ways of Learning: A Resource for More Purposeful, Effective, and Enjoyable College Teaching, Second Edition” with James R. Davis. The book explores practical approaches to improving college teaching and student learning experiences. Buy the book. College of Business Faculty At the 2026 Western Decision Sciences Institute international conference, Sally Baalbaki-Yassine, Ph.D., Debora Gilliard, Ph.D., and David Lynn Hoffman, Ph.D., from the College of Business received the Best Case Study Paper Award for “Oreo: A Global Success Story in Brand Evolution and Market Leadership.” Lisa McVicker, Ph.D., and Apryl Brodersen, Ph.D., also had their paper, “Electronic Performance Monitoring: Employer Panacea or Legal Quagmire?” accepted for publication in the Journal of Business Leadership. Community Engagement Exchange Program Metropolitan State University of Denver was selected to host international Fellow Aleja Henao Espitia of Bogotá, Colombia through the Community Engagement Exchange program funded by the U.S. Department of State. View Espitia's LinkedIn profile. David Varel, Ph.D., College of Letters, Arts and Sciences MSU Denver historian David Varel, Ph.D., has been awarded a 2026 ACLS Fellowship by the American Council of Learned Societies. The fellowship program supports outstanding scholarship in the humanities and social sciences, and selected just 63 scholars from more than 2,000 applicants this year. Varel’s project, “The Black Chicago School: Academic Activism in the Age of American Apartheid,” explores the work of Black scholars who challenged scientific racism, built alternative institutions and helped lay the foundation for the modern civil rights movement. The fellowship provides up to $60,000 to support full-time research and writing. Learn more about the fellowship. MSU Denver Office of Financial Aid Team Several MSU Denver employees were recognized for leadership and service during the Colorado Association of Financial Aid Administrators (CAFAA) conference held in May in Crested Butte. Don Holtzen, interim associate director of systems, chaired the conference and was recognized for his service as CAFAA conference chair and technology chair during the 2025-26 term. Holtzen also received the Postsecondary Institution Professional of the Year award, which recognizes financial-aid professionals who have made significant contributions to their institutions and to CAFAA. Tori Pacheco, associate director of Student Services, helped design décor and facilitate the conference and was recognized for her service as CAFAA secretary during the 2025-26 term. Destiny Candelaria, call center coordinator, served on the conference planning committee and presented on One Stops during the event. Michael Nguyen, executive director of Financial Aid and Scholarships, assisted as a CAFAA board member and was recognized for serving as president-elect during the 2025-26 term. Richard Balbag, program assistant I, received the Distinguished Support Staff Member of the Year award, honoring staff members who have made exceptional contributions to their financial-aid offices. Military Friendly Recognition Military Friendly has awarded MSU Denver Gold Status as a military-friendly university and ranked the University No. 7 nationally for military spouses. The recognition reflects MSU Denver’s strong support systems for veterans and military spouses, including transfer credit assistance and retention-focused resources. As of 2026, 1,050 military-connected students are enrolled at the University, advancing institutional priorities around serving veterans and supporting student retention. MSU Denver Cheer Club The MSU Denver Cheer Club earned third place in the 4-Year College Small Coed Intermediate division at the USA Spirit Nationals. Celebrate the win on Instagram. MSU Denver Cybersecurity Team An MSU Denver cybersecurity team earned first place in the Strategist category at the 2026 CYBER RECon National Competition hosted at Fort Meade, Maryland, by U.S. Cyber Command. Led by Jeffrey London, Ph.D., and undergraduate student Matthew Bopp, the team competed against universities and law schools nationwide with its 30-page legal analysis on cybersecurity and free speech titled “Freedom of Speech and MDM: Misinformation, Disinformation, and Malinformation.” The paper also earned Bopp a personal invitation to apply to the University of Maryland School of Law. MSU Denver Debate Team MSU Denver Debate won the 2026 Sierra Sustainability Summit hosted at Yosemite National Park in April. Students Kat Conte and Simon Bernhard bested teams from George Washington University, Gallaudet University, Cal Poly San Luis Obispo, the University of San Francisco and Tennessee Tech in the modified present-and-defend style competition. Their proposal recommended adapting Colorado’s Keep Colorado Wild Pass model to support California state parks facing budget constraints. Learn about the summit. MSU Denver Women’s Golf MSU Denver Women’s Golf was represented on the national stage this month as junior Neige Dunn competed as an individual at the NCAA West Regional. She became the first Roadrunner in 10 years to qualify for NCAA Regionals as an individual. Get the details.
What we know about the 2026 Ebola outbreak as first American tests positive
The type of Ebolavirus causing the outbreak in DRC, called Bundibugyo, is less common than other types of Ebola. There are no vaccines or drugs available to treat it.
Abortion Pill Lawsuit Leaves Trump Silent, and in a Political Bind
Louisiana wants the Food and Drug Administration to curtail access to the medication. Doing so could cost Republicans at the polls.
Science Says People Who Lose Weight on GLP-1 Drugs Face More Stigma Than People Who Stay Overweight. That's Just Weird
I have thoughts.
Will Ferrell's rock star look-alike tricks “SNL” audience with host monologue
Red Hot Chili Peppers drummer Chad Smith stepped out instead of the "Saturday Night Live" alum.
Andalucíans to vote in election seen as gauge of Spain’s wider political change
Conservatives expected to keep majority as socialists face drubbing and ballot tests trajectory of far-right Vox party
SF business owners in Mission District say drug use, encampment fires are worsening
Small business owners on Clinton Park and Stevenson Street in the Mission say conditions have worsened in recent months as enforcement and encampment cleanups at major hotspots increase in other parts of the city.
Katherine Tucker: Landrum, Business Consultant
Katherine Tucker is a business professional at Landrum, partnering with leaders across industries to strengthen organizations, support workforce strategy, and
Federal 340B drug program accused of health care abuse
FOX Business' Gerri Willis reports on health care abuse accusations against the federal 340B drug program and the impact of costs on 'Varney & Co.'
Philippines vows to hand fugitive senator to ICC following shootout
Senator Ronald 'Bato' dela Rosa wanted for alleged role as top enforcer of ex-president Duterte's deadly drug war.
Rocket Science Health validates targeted olfactory-cleft deposition in non-human primates ahead of the 4th Nasal Formulation & Delivery Summit
As the pace of modern drug discovery accelerates, the industry is increasingly recognizing that a breakthrough molecule is only as effective as its ability to reach the target site.
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
The court’s order allows women seeking abortions to continue obtaining the drug, mifepristone, at pharmacies or through the mail, without an in-person visit to a doctor. Access is likely to remain uninterrupted at least until into next year as the case plays out, including a potential appeal to the high court.
Gavin Newsom Beats The Drum For Nationwide Entertainment Industry Incentives, And Dances Around His Presidential Aspirations
Throughout his decades in politics, Gavin Newsom has been called everything under the California sun by friends and foes alike, but there is one moniker the two-term Golden State governor embraces, th...
Twins with Batten disease benefit from UNC Health drug trial
Therapy designed to mask the girls’ affected genes helps Amelia and Makenzie Kahn deal with the rare neurological condition.
KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently — The Monitor
KFF’s latest Health Tracking Poll finds that confidence in the independence of key government health agencies overseeing food and drug safety and public health is low among the public and across partisans. Most of the public also share a distrust of agriculture, food, and pharmaceutical companies to act in the public’s best interest, compared with doctors and health care providers who are much more trusted among the public.
Druski’s Wild BET Awards Promo Explains Exactly Why BET Chose Him as Its Youngest Host Ever
Druski is not promoting the 2026 BET Awards like a traditional awards-show host. He is turning the entire rollout into a comedy universe built around ... Read More
Puberty field trip? Philly-area students get a front-row seat to health education
Lankenau Medical Center’s health education center provides free interactive programs on nutrition, exercise, drugs and alcohol, puberty and more.
This lesser-known cholesterol can quadruple your heart-attack risk
Heart specialists now recommend that everyone get tested for lipoprotein(a). Here’s what to know about it.
Routine testing is needed to locate patients who may not benefit from clopidogrel
Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA)...
Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment
Ivermectin prescriptions spiked among cancer patients after Mel Gibson endorsed antiparasitic drugs on Joe Rogan's podcast, a new JAMA study reports.
Drug counselor who gave Matthew Perry fatal ketamine gets 2 years in prison
A drug addiction counselor who delivered the fatal ketamine doses to Matthew Perry was sentenced to two years in prison for his role in the actor’s death.
An unloved health-care stock gets a welcome nod in this AI-obsessed market
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
R.I. Governor McKee’s charter school conundrum
McKee turned heads when he said he’d be open to imposing a moratorium on new charter schools, but after taking another look at the bill, McKee isn’t quite ready to commit to signing it if it makes it to his desk.
FDA chief’s resignation widens a leadership gap at the nation’s health department
Dr. Marty Makary's resignation from his post atop the Food and Drug Administration is widening a leadership gap that already existed at the U.S. Department of Health and Human Services.
Extreme heat is worsening faster for Black Americans
Bill Cassidy's can't-win conundrum, what RFK Jr. gets right and wrong about antidepressants, and more health news
The cinema effect: Turning films into a gateway to science
The sci-fi film Project Hail Mary, currently in theaters, is capturing the attention of both audiences and the scientific community for its science-based content. It manages to engage viewers with complex, cutting-edge topics — from astrophysics to language — without sacrificing entertainment. Yet not all films strike this balance. Many, unlike this recent production, have promoted inaccurate or even misleading scientific ideas, and thanks to their wide reach, have contributed to shaping distorted public perceptions of science. Precisely by harnessing the power of cinematic storytelling, Hildrun Walter, Fritz Treiber and colleagues have used films as a tool to foster engagement and dialogue between scientists and the public. Their innovative format, Science & Cinema, described in a new paper published in JCOM, proves both effective and potentially easy to replicate.
AI Life Science Firm Metis TechBio Set for HK Debut After IPO
Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.
Marty Makary out as head of US Food and Drug Administration
Makary is the latest top health official to be ousted under Health Secretary Robert F Kennedy Jr.
FDA chief to depart after Trump signed off on ousting him
Food and Drug Administration Commissioner Marty Makary is leaving the Trump administration, according to two people familiar with the situation, after President Donald Trump signed off on a plan to fire him last week.
FDA commissioner Makary is resigning, sources say
U.S. Food and Drug Commissioner Marty Makary plans to resign on Tuesday, according to two sources familiar with the situation, the latest leadership change at the federal health department which comes after weeks of public speculation and a mounting pressure campaign.
Supreme Court extends mifepristone deadline
The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds
Trump's FDA boss resigning as admin taps next acting leader
FDA Commissioner Marty Makary resigns after clashes over the abortion drug mifepristone and mounting pro-life group frustrations.
New drugs could wipe out the “zombie cells” linked to cancer and aging
Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These senescent cells survive by relying on a protective protein called GPX4, even while sitting on the edge of a deadly iron-triggered collapse. New drugs remove that protection, causing the cells to self-destruct. In mice, the approach reduced tumor size and boosted survival, hinting at a promising new cancer therapy.
Obesity Drug Prices Undercut Healthcare Savings, CVS CEO Says
CVS Health Corp. Chief Executive Officer David Joyner said that drugmakers must significantly reduce the price of anti-obesity medicines before the drugs will save money for commercial health insurance plans.
Alcohol is wreaking havoc on U.S. public health. American society looks the other way
The Deadliest Drug, a new investigative series, shows that the alcohol epidemic is a generational failure of the medical and public health systems, of industry, and of government.